PFM Health Sciences’s Dynavax Technologies DVAX Stock Holding History

PFM Health Sciences’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,704,917	Closed	-$34.9M	–	76
2023 Q2	$34.9M	Sell	2,704,917 -1,100,453	-29%	-$12.5M	1.36%	34
2023 Q1	$37.3M	Hold	3,805,370	–	–	1.65%	29
2022 Q4	$40.5M	Hold	3,805,370	–	–	1.45%	27
2022 Q3	$39.7M	Hold	3,805,370	–	–	1.44%	30
2022 Q2	$47.9M	Hold	3,805,370	–	–	1.83%	18
2022 Q1	$41.3M	Hold	3,805,370	–	–	1.54%	27
2021 Q4	$53.5M	Buy	3,805,370 +521,800	+16%	+$8.59M	1.82%	20
2021 Q3	$63.1M	Buy	3,283,570 +292,800	+10%	+$3.89M	1.85%	17
2021 Q2	$29.5M	Hold	2,990,770	–	–	0.92%	41
2021 Q1	$29.4M	Buy	2,990,770 +53,780	+2%	+$443K	0.9%	46
2020 Q4	$13.1M	Hold	2,936,990	–	–	0.46%	66
2020 Q3	$12.7M	Buy	2,936,990 +1,793,464	+157%	+$12.8M	0.59%	55
2020 Q2	$10.1M	Buy	+1,143,526	New	+$5.78M	0.53%	59

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PFM Health Sciences's DVAX Position: Q3 2023 in Review

PFM Health Sciences sold out of Dynavax Technologies (DVAX) in Q3 2023, closing a stake of 2,704,917 shares — an estimated $34.9M sold.

PFM Health Sciences first reported a position in DVAX in Q2 2020 and held it in 13 quarters. The position peaked at $63.1M in Q3 2021. 225 funds tracked by Wall St. Rank hold DVAX as of Q3 2023.

PFM Health Sciences reported no remaining Dynavax Technologies position as of Q3 2023 after selling out during the quarter.
PFM Health Sciences sold 2,704,917 Dynavax Technologies shares in Q3 2023, an estimated $34.9M.
PFM Health Sciences first reported a position in Dynavax Technologies in Q2 2020 and held it in 13 quarters.
PFM Health Sciences's Dynavax Technologies position peaked at $63.1M in Q3 2021.
225 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2023.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.